1. Arylamine N-acetyltransferase 1 deficiency inhibits drug-induced cell death in breast cancer cells: switch from cytochrome C-dependent apoptosis to necroptosis

   • Courtney E. McAleese
   • Neville J. Butcher
   • Rodney F. Minchin

   Preclinical study Open access 02 August 2022 Pages: 223 - 236

   

2. Clever-1 positive macrophages in breast cancer

   • Minna Mutka
   • Reetta Virtakoivu
   • Päivi Heikkilä

   Preclinical study Open access 02 August 2022 Pages: 237 - 248

   

3. The clinical relevance of various methods of classifying ipsilateral breast tumour recurrence as either true local recurrence or new primary

   • Jan J. Jobsen
   • Henk Struikmans
   • Harald J. Heijmans

   Preclinical study 08 August 2022 Pages: 249 - 262

   

4. BluePrint breast cancer molecular subtyping recognizes single and dual subtype tumors with implications for therapeutic guidance

   • Midas M. Kuilman
   • Architha Ellappalayam
   • Annuska M. Glas

   Preclinical study Open access 19 August 2022 Pages: 263 - 274

   

5. An open label, randomized phase 2 trial assessing the impact of food on the tolerability of abemaciclib in patients with advanced breast cancer

   • Elgene Lim
   • Frances Boyle
   • Meritxell Bellet Ezquerra

   Clinical trial Open access 01 August 2022 Pages: 275 - 287

   

6. Surgical and obstetric outcomes of breast cancer surgery during pregnancy: a nationwide database study in Japan

   • Takaaki Konishi
   • Michimasa Fujiogi
   • Hideo Yasunaga

   Clinical trial 02 August 2022 Pages: 289 - 299

7. Neoadjuvant endocrine therapy for strongly hormone receptor-positive and HER2-negative early breast cancer: results of a prospective multi-center study

   • Xinguang Wang
   • Zhaoqing Fan
   • Tao Ouyang

   Clinical trial 02 August 2022 Pages: 301 - 310

   

8. Efficacy and impact of SARS-CoV-2 vaccination on cancer treatment for breast cancer patients: a multi-center prospective observational study

   • Mitsuo Terada
   • Naoto Kondo
   • Tatsuya Toyama

   Clinical trial 08 August 2022 Pages: 311 - 323

   

9. The influence of body mass index on the tolerability and effectiveness of full-weight-based paclitaxel chemotherapy in women with early-stage breast cancer

   • Lishi Lin
   • Marcel Soesan
   • Alwin D. R. Huitema

   Clinical trial Open access 16 August 2022 Pages: 325 - 331

   

10. Neratinib in advanced HER2-positive breast cancer: experience from the royal Marsden hospital

    • Niamh Cunningham
    • Scott Shepherd
    • Alicia F. C. Okines

    Clinical trial 17 August 2022 Pages: 333 - 340

    

11. Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: a feasibility study

    • Elaine M. Walsh
    • Ayca Gucalp
    • Tiffany A. Traina

    Clinical trial 20 August 2022 Pages: 341 - 351

    

12. Lifetime personal cigarette smoking and risk of young-onset breast cancer by subtype among non-Hispanic Black and White women in the Young Women's Health History Study

    • Ugonna Ihenacho
    • Ann S. Hamilton
    • Ellen M. Velie

    Epidemiology 04 August 2022 Pages: 353 - 366

13. Correlation of tumour subtype with long-term outcome in small breast carcinomas: a Swedish population-based retrospective cohort study

    • Gunilla Rask
    • Anoosheh Nazemroaya
    • Malin Sund

    Epidemiology Open access 06 August 2022 Pages: 367 - 377

    

14. Impact of persistent peripheral neuropathy on health-related quality of life among early-stage breast cancer survivors: a population-based cross-sectional study

    • Kristina Engvall
    • Henrik Gréen
    • Elisabeth Åvall-Lundqvist

    Epidemiology Open access 09 August 2022 Pages: 379 - 391

    

15. A mixed-methods study of the technical feasibility and patient acceptability of a real-time adherence monitor in breast cancer survivors taking adjuvant endocrine therapy

    • Emma E. Bright
    • Sarah R. Genung
    • Joanna J. Arch

    Epidemiology 12 August 2022 Pages: 393 - 399

    

16. Cardiotoxicity among socioeconomically marginalized breast cancer patients

    • Yan Lu
    • Aaron W. Gehr
    • Rohit P. Ojha

    Epidemiology Open access 15 August 2022 Pages: 401 - 411

    

17. Barriers to breast reconstruction for socioeconomically disadvantaged women

    • Trista J. Stankowski
    • Jessica R. Schumacher
    • Heather B. Neuman

    Epidemiology 15 August 2022 Pages: 413 - 419

18. Dose-dependent relation between metformin and the risk of hormone receptor-positive, her2-negative breast cancer among postmenopausal women with type-2 diabetes

    • Soumya G. Chikermane
    • Manvi Sharma
    • Michael L. Johnson

    Epidemiology 15 August 2022 Pages: 421 - 430

    

19. Prevalence of BRCA1 and BRCA2 pathogenic variants in 8627 unselected patients with breast cancer: stratification of age at diagnosis, family history and molecular subtype

    • Fan Zang
    • Xinyun Ding
    • Yuntao Xie

    Epidemiology 16 August 2022 Pages: 431 - 439

20. Treatment of HR+/HER2− breast cancer in urban mainland China: results from the CancerMPact Survey 2019

    • Bhavna Murali
    • Laura Durbin
    • Otávio Clark

    Epidemiology Open access 20 August 2022 Pages: 441 - 451

21. Contribution of BRCA1 5382insC mutation to triplene-gative and luminal types of breast cancer in Ukraine

    • Anastasiia Samusieva
    • Svitlana Serga
    • Iryna Kozeretska

    Brief Communication 05 August 2022 Pages: 453 - 459

22. Letter to the editor regarding “Hsp90 inhibitor-loaded IR780 micelles for mitochondria-targeted mild-temperature photothermal therapy in xenograft models of human breast cancer”

    • Jianquan Yang
    • Wen Guo
    • Man Lu

    Letter to the Editor 05 August 2022 Pages: 461 - 462